Anemia of Prematurity - Portal Neonatal

MISCELLANEOUS Section 9 of 11
Medical/Legal Pitfalls:
• Delay in diagnosis and initiation of treatment may result in death of the infant.
• Failure to provide prophylaxis to women with GBS infection may create liability if the infant
subsequently becomes ill.
Special Concerns: The Joint Commission on Infant Hearing of the AAP recommends that infants
who received aminoglycosides should have audiology screening before discharge. Screen these
infants again at 3 months, but no later than 6 months, to determine whether damage has occurred.
PICTURES Section 10 of 11
Picture 1. Prevention strategy for early-onset group B streptococcal (GBS) disease using risk
factors without prenatal culture screening.
Picture 2. Prevention strategy for early-onset group B streptococci (GBS) disease using prenatal
culture screening at 35-37 weeks of gestation. Plus sign indicates positive culture results; minus sign
indicates negative culture results.
BIBLIOGRAPHY Section 11 of 11
• American Academy of Pediatrics: Red Book 2000. 25th ed. 2000; 20-26, 241-2, 537-543.
• Hickman ME, Rench MA, Ferrieri P, Baker CJ: Changing epidemiology of group B
streptococcal colonization. Pediatrics 1999 Aug; 104(2 Pt 1): 203-9[Medline].
• Kemp AS, Campbell DE: The neonatal immune system. Seminar in Neonatology 1996; 1: 67-
75.
• Klein JO, Marcy SM: Bacterial Sepsis and Meningitis. Infectious Diseases of the Fetus &
Newborn Infant. 4th ed. 1995; 835-878.
• Kocherlakota P, La Gamma EF: Preliminary report: rhG-CSF may reduce the incidence of
neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998 Nov;
102(5): 1107-11[Medline].
• McKenna DS, Iams JD: Group B streptococcal infections. Seminars in Perinatology 1998; 22:
267-76.